Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Brain Neoplasms 2 Xanthomatosis, Cerebrotendinous 1 Oligodendroglioma 1 Melanoma 1 Influenza, Human 1 Advanced Fallopian Tube Carcinoma 1

Interventions

pembrolizumab 140 Nivolumab 117 Ipilimumab 69 Cyclophosphamide 33 Specimen Handling 31 Magnetic Resonance Spectroscopy 28 trametinib 23 binimetinib 22 fludarabine 21 Interleukin-2 20 dabrafenib 19 relatlimab 17 encorafenib 17 Biopsy 17 CTLA-4 Antigen 16 cemiplimab 15 atezolizumab 15 aldesleukin 15 Radiosurgery 15 fludarabine phosphate 14 Opdualag 14 Radiotherapy 11 lenvatinib 10 Blood Specimen Collection 10 lifileucel 9 spartalizumab 8 Paclitaxel 8 Cisplatin 8 Bevacizumab 8 cobimetinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Diphtheria-Tetanus Vaccine × 1 year × Clear all

NCT05077137 2025-08-27

TdVax

Duke University

Phase 1 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡